Example: Heart Attack
Clinical Trials on Uterine Cervicitis
Total 1 results
-
NCT01375439CompletedConditions: Pregnancy, Vulvovaginitis, Uterine Cervicitis, Pregnancy Outcome
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Medical Conditions
- COVID-19
- 18F-FDG
- Arthralgia
- Cannabis Use, Unspecified
- Dry Eye Disease
- Ear Cartilage
- Effects of; Exertion
- Facial Volume Loss
- Final Loss of Restauration
- Opioid, Moderate Cancer Pain, Transdermal Fentanyl, 12.5ug/h, Opioid-naive
- Perimenopausal Disorder
- Perinatal Death
- Spectrum of Altitude-associated Neurologic Forms of Altitude
- Tubal Excision
- View Full List
Sponsors and Collaborators
- Asian Center for Health Education
- Center for Medical Technology Policy
- HelixBind, Inc.
- Hospitalsenheden Vest
- ICL Pharma
- IRSAT DTA Burkina Faso
- LIANA FATTORI ABATI
- Ministry of Public Health, Argentina
- Richard H Epstein
- Shanghai Center of Biomedicine Development
- Shanxi Kangbao Biological Product Co., Ltd.
- Sir Run Shaw Hospital
- Zhongrong Miao
- View Full List
Drug Interventions
- 12 mg betamethasone + placebo
- Bryophyllum p.
- CCS1477
- Cinnamon or placebo 500 mg capsule twice daily
- Clofarabine 40mg/m^2
- Delayed-Release (DR) Prednisone
- Experimental - 4% Sodium Bicarbonate
- Naproxen Sodium 440 mg (BAYH6689)
- Treatment of psychiatric symptoms associated to alcoholism
- VOX
- Venetoclax+Decitabine
- low dexmedetomidine, low propofol
- tazarotene
- View Full List
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations